Harrow
Kati Gammill is a seasoned marketing professional with a strong background in brand management and marketing communications. Currently serving as a Senior Brand Manager at Harrow since January 2023, Kati has previously held significant roles including Director of Brand Management at Agency Habitat, and Senior Digital Account Manager at Schaefer Advertising Co. Additional experience includes marketing positions at Pegasus Logistics Group, Endeavor Acquisitions, Texas Wesleyan University, Alcon, Canon Solutions America, Burlington County College, and Bennigan's Bar and Grill. Kati holds a Bachelor of Science degree in Business Marketing and Business Finance from Seton Hall University.
This person is not in any offices
Harrow
2 followers
Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical products. Harrow also owns and operates ImprimisRx, the leading U.S. ophthalmic‑focused pharmaceutical compounding business, which also serves as a mail-order pharmacy licensed to ship prescription medications in all 50 states. Harrow has non-controlling equity positions in Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc., companies that began as subsidiaries of Harrow. Harrow also owns royalty rights in four late-stage drug candidates being developed by Surface and Melt.